Details for New Drug Application (NDA): 205824
✉ Email this page to a colleague
The generic ingredient in ENTECAVIR is entecavir. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the entecavir profile page.
Summary for 205824
Tradename: | ENTECAVIR |
Applicant: | Accord Hlthcare |
Ingredient: | entecavir |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Aug 25, 2017 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Aug 25, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription